Medicare Enrolled

Dr. Vairavan Subramanian, M.D.

Urology Physician · Plano, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
4708 ALLIANCE BLVD, Plano, TX 75093
9725667765
In practice since 2007 (18 years)
NPI: 1821282849 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Subramanian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Subramanian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Subramanian

Dr. Vairavan Subramanian is an urology physician in Plano, TX, with 18 years in practice. Based on federal Medicare data, Dr. Subramanian performed 4,656 Medicare services across 3,135 unique beneficiaries.

Between the years covered by Open Payments, Dr. Subramanian received a total of $2,295 from 36 pharmaceutical and/or device companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Subramanian is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 25% volume in TX$ $2,295 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,656
Medicare services
Top 25% in TX for urology physician
3,135
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~259 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Automated urinalysis870$2$5
Office visit, established patient (20-29 min)613$62$183
Office visit, established patient (30-39 min)520$87$259
Chronic care management, first 20 min/month468$46$127
Blood draw (venipuncture)337$8$17
Bladder ultrasound after voiding268$7$22
PSA test (prostate cancer screening)238$18$37
New patient office visit (45-59 min)164$119$336
Diagnostic exam of bladder and urethra using an endoscope154$181$494
Urine culture, bacterial colony count133$8$16
Urine culture, bacterial identification119$8$16
Leuprolide acetate (for depot suspension), 7.5 mg112$136$377
Chronic care management, additional 20 min/month98$34$96
Testosterone (hormone) level, total68$25$52
Bacterial culture, aerobic66$8$16
Antibiotic sensitivity test66$8$17
Simple insertion of temporary bladder tube55$46$126
New patient office visit (30-44 min)45$79$226
Office visit, established patient, complex (40-54 min)36$127$363
Comprehensive metabolic blood panel34$10$21
Ultrasound scan of pelvic region through rectum29$103$283
Hospital follow-up visit, low complexity26$38$95
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle20$25$70
Insertion of stent in ureter using an endoscope19$103$361
Crushing of stone of ureter with insertion of stent using an endoscope19$336$815
Biopsy of prostate gland16$172$492
Initial hospital admission, moderate complexity15$97$262
Imaging of urinary tract following injection of a contrast agent14$19$49
Hospital follow-up visit, moderate complexity12$62$155
Measurement of total estradiol (hormone)11$27$56
Initial hospital admission, high complexity11$136$353
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
7.5% medium
91.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,295
Total received (2018-2024)
Avg $328/year across 7 years
Bottom 43% in TX for urology physician
36
Companies
84
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,251 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$44 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$830
2023
$334
2022
$297
2021
$106
2020
$86
2019
$252
2018
$389

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$307
Boston Scientific Corporation
$241
Astellas Pharma US Inc
$218
Janssen Biotech, Inc.
$183
Dendreon Pharmaceuticals LLC
$143
PFIZER INC.
$119
BOSTON SCIENTIFIC CORPORATION
$116
Olympus America Inc.
$97
Sumitomo Pharma America, Inc.
$72
Tolmar, Inc.
$67
C. R. BARD, INC. & SUBSIDIARIES
$60
Blue Earth Diagnostics Limited
$56
Bayer Healthcare Pharmaceuticals Inc.
$53
Innovation Technologies Inc
$50
Myovant Sciences Inc.
$44
Merck Sharp & Dohme LLC
$42
Allergan Inc.
$39
STERIS CORPORATION
$31
Medtronic USA, Inc.
$28
Progenics Pharmaceuticals, Inc.
$27
Tempus AI, Inc
$25
Novartis Pharmaceuticals Corporation
$25
Bayer HealthCare Pharmaceuticals Inc.
$25
Abbott Laboratories
$24
UROVANT SCIENCES INC
$21
AKRIMAX PHARMACEUTICALS, LLC
$21
Pacira Pharmaceuticals Incorporated
$20
Pharmacyclics LLC, an AbbVie Company
$20
AstraZeneca Pharmaceuticals LP
$19
Cook Medical LLC
$16
MEDIVATION FIELD SOLUTIONS LLC
$15
C. R. Bard, Inc. & Subsidiaries
$15
UroGen Pharma, Inc.
$15
Antares Pharma, Inc.
$15
Allergan, Inc.
$13
AbbVie, Inc.
$12
Top 3 companies account for 33.4% of total payments
Associated products mentioned in payments ›
ADVANTAGE FIT · Axumin · BOTOX · BOTOX THERAPEUTIC · COOK · ELIGARD · ERLEADA · Erleada · Exparel · FREESTYLE LIBRE 3 · GEMTESA · IMBRUVICA · INTERSTIM · IRRISEPT · JELMYTO · KEYTRUDA · LITHOVUE · LYNPARZA · LithoVue · Lupron · MYRBETRIQ · Moses 550 DFL · Myrbetriq · NA · NANOKNIFE · NOCDURNA · Nubeqa · ORGOVYX · Olympus Cysto-Resection · PLUVICTO · PROVENGE · PYLARIFY · REZUM · Rezum Generator · SKYLITE · SpaceOAR VUE System - 10mL · Stendra · XTANDI · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $49 per 100 Medicare services performed
Looking for a urology physician in Plano?
Compare urology physicians in the Plano area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
132
Per 100K population
11.8
County median income
$117,588
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Subramanian is a clinical cardiology specialist, with above-average Medicare volume (top 25% in TX), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Subramanian experienced with automated urinalysis?
Based on Medicare claims data, Dr. Subramanian performed 870 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Subramanian receive payments from pharmaceutical companies?
Yes. Dr. Subramanian received a total of $2,295 from 36 companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Subramanian's costs compare to other urology physicians in Plano?
Dr. Subramanian's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Subramanian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →